As of April 2025 ResMed has a market cap of NZ$58.01 Billion. This makes ResMed the world's 576th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | NZ$58.01 B | -4.42% |
2024 | NZ$60.69 B | 51.7% |
2023 | NZ$40.01 B | -16.68% |
2022 | NZ$48.01 B | -13.88% |
2021 | NZ$55.75 B | 30.61% |
2020 | NZ$42.69 B | 28.31% |
2019 | NZ$33.27 B | 36.8% |
2018 | NZ$24.32 B | 43.74% |
2017 | NZ$16.92 B | 34.01% |
2016 | NZ$12.62 B | 14.98% |
2015 | NZ$10.98 B | 9.34% |
2014 | NZ$10.04 B | 23.82% |
2013 | NZ$8.11 B | 11.96% |
2012 | NZ$7.24 B | 51.36% |
2011 | NZ$4.78 B | -30.53% |
2010 | NZ$6.89 B | 27.32% |
2009 | NZ$5.41 B | 10.71% |
2008 | NZ$4.88 B | -8.16% |
2007 | NZ$5.32 B | -0.66% |
2006 | NZ$5.35 B | 34.46% |
2005 | NZ$3.98 B | 63.07% |
2004 | NZ$2.44 B | 13.96% |
2003 | NZ$2.14 B | 11.2% |
2002 | NZ$1.92 B | -54.01% |
2001 | NZ$4.19 B | 49.56% |
2000 | NZ$2.80 B | 133.67% |
1999 | NZ$1.19 B | -5.32% |
1998 | NZ$1.26 B | 260.64% |
1997 | NZ$0.35 B | 56.91% |
1996 | NZ$0.22 B |
On Apr 24th, 2025 the market cap of ResMed was reported to be: